Investors
Oxurion/Investors/News

Investor news.

Regulated information, press releases and inside information published by Oxurion. Documents are available as PDF in English, Dutch and French.

473 press releases
12 Oct 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notifications from Market Wizards B.V. and Atlas Special Opportunities II LLC

ENNL
9 Oct 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Market Wizards B.V.

ENNL
8 Oct 2026
Regulated

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

ENNL
6 Oct 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notifications from Jason Eastwick Carroll, HRT Capital LLC, Hudson River Trading LLC and HRTEU Limited

ENNL
30 Sep 2026
Regulated

Oxurion Publishes First Half 2026 Results

ENNLFR
30 Sep 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC, The Goldman Sachs Group, Inc and Goldman Sachs International

ENNL
30 Sep 2026
Inside informationRegulated

Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO

ENFR
25 Sep 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

ENNL
23 Sep 2026
Regulated

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

ENNL
14 Sep 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
28 Aug 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
21 Jul 2026

Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

ENFR
…